These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 39066219)

  • 41. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
    Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome.
    Ansari MH; Ebrahimi M; Fattahi MR; Gardner MG; Safarpour AR; Faghihi MA; Lankarani KB
    BMC Microbiol; 2020 May; 20(1):123. PubMed ID: 32429898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease.
    Xing Y; Liu Y; Sha S; Zhang Y; Dou Y; Liu C; Xu M; Zhao L; Wang J; Wang Y; Ma X; Yan Q; Kong X
    J Med Virol; 2024 Jul; 96(7):e29781. PubMed ID: 38961767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.
    Mei L; Zhou J; Su Y; Mao K; Wu J; Zhu C; He L; Cui Y
    BMC Gastroenterol; 2021 Mar; 21(1):105. PubMed ID: 33663411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome.
    Pecyna P; Gabryel M; Mankowska-Wierzbicka D; Nowak-Malczewska DM; Jaskiewicz K; Jaworska MM; Tomczak H; Rydzanicz M; Ploski R; Grzymislawski M; Dobrowolska A; Gajecka M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome.
    Polster A; Öhman L; Tap J; Derrien M; Le Nevé B; Sundin J; Törnblom H; Cvijovic M; Simrén M
    Sci Rep; 2021 Mar; 11(1):5521. PubMed ID: 33750831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
    Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA
    Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.
    Noorbakhsh H; Yavarmanesh M; Mortazavi SA; Adibi P; Moazzami AA
    Eur J Nutr; 2019 Dec; 58(8):3109-3119. PubMed ID: 30392136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort.
    Brunkwall L; Ericson U; Nilsson PM; Orho-Melander M; Ohlsson B
    J Gastroenterol Hepatol; 2021 Jan; 36(1):174-180. PubMed ID: 32428346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea.
    Mohammadzadeh N; Kalani BS; Bolori S; Azadegan A; Gholami A; Mohammadzadeh R; Masjedian Jazi F
    Acta Microbiol Immunol Hung; 2019 Jun; 66(2):189-202. PubMed ID: 31062602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer.
    Zhang P; Shi H; Guo R; Li L; Guo X; Yang H; Chang D; Cheng Y; Zhao G; Li S; Zhong Q; Zhang H; Zhao P; Fu C; Song Y; Yang L; Wang Y; Zhang Y; Jiang J; Wang T; Zhao J; Li Y; Wang B; Chen F; Zhao H; Wang Y; Wang J; Ma S
    J Med Virol; 2024 Jul; 96(7):e29809. PubMed ID: 39016466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Machine learning-causal inference based on multi-omics data reveals the association of altered gut bacteria and bile acid metabolism with neonatal jaundice.
    Chen W; Zhang P; Zhang X; Xiao T; Zeng J; Guo K; Qiu H; Cheng G; Wang Z; Zhou W; Zeng S; Wang M
    Gut Microbes; 2024; 16(1):2388805. PubMed ID: 39166704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
    Gargari G; Mantegazza G; Taverniti V; Gardana C; Valenza A; Rossignoli F; Barbaro MR; Marasco G; Cremon C; Barbara G; Guglielmetti S
    Gut Microbes; 2023 Dec; 15(2):2274128. PubMed ID: 37910479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    Chen H; Ou R; Tang N; Su W; Yang R; Yu X; Zhang G; Jiao J; Zhou X
    J Transl Med; 2023 Feb; 21(1):117. PubMed ID: 36774467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Potential Role for Stress-Induced Microbial Alterations in IgA-Associated Irritable Bowel Syndrome with Diarrhea.
    Rengarajan S; Knoop KA; Rengarajan A; Chai JN; Grajales-Reyes JG; Samineni VK; Russler-Germain EV; Ranganathan P; Fasano A; Sayuk GS; Gereau RW; Kau AL; Knights D; Kashyap PC; Ciorba MA; Newberry RD; Hsieh CS
    Cell Rep Med; 2020 Oct; 1(7):. PubMed ID: 33196055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.
    Fodor AA; Pimentel M; Chey WD; Lembo A; Golden PL; Israel RJ; Carroll IM
    Gut Microbes; 2019; 10(1):22-33. PubMed ID: 29708822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.